Paul J. Clancy
2016
In 2016, Paul J. Clancy earned a total compensation of $5.4M as Former Executive Vice President, Finance and Chief Financial Officer at Biogen, a 36% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $55,376 |
|---|---|
| Non-Equity Incentive Plan | $728,818 |
| Salary | $844,600 |
| Stock Awards | $3,556,773 |
| Other | $199,635 |
| Total | $5,385,202 |
Clancy received $3.6M in stock awards, accounting for 66% of the total pay in 2016.
Clancy also received $55.4K of change in pension value and nonqualified deferred compensation earnings, $728.8K in non-equity incentive plan, $844.6K in salary and $199.6K in other compensation.
Rankings
In 2016, Paul J. Clancy's compensation ranked 1,433rd out of 14,075 executives tracked by ExecPay. In other words, Clancy earned more than 89.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,433 out of 14,075 | 90th |
Division Manufacturing | 486 out of 5,486 | 91st |
Major group Chemicals And Allied Products | 135 out of 1,900 | 93rd |
Industry group Drugs | 91 out of 1,543 | 94th |
Industry Biological Products, Except Diagnostic Substances | 18 out of 287 | 94th |
Source: SEC filing on April 27, 2018.
Clancy's colleagues
We found five more compensation records of executives who worked with Paul J. Clancy at Biogen in 2016.
2016
George Scangos
Biogen
Chief Executive Officer
2016
Michel Vounatsos
Biogen
Chief Executive Officer
2016
Michael Ehlers
Biogen
Executive Vice President, Research & Development
2016
Kenneth DiPietro
Biogen
Former Executive Vice President, Human Resources
2016
Susan Alexander
Biogen